IL22 and metabolic dysfunction-associated steatohepatitis: In NASH, an increase of Th17 cells during the first step of disease (i.e., when the liver begins to be damaged) precedes infiltration of “hepatoprotective” IL-22 secreting cells, and a second expansion of Th17 cells54–56.